See every side of every news story
Published loading...Updated

Two telehealth firms turn to branded Zepbound as restrictions loom on copies

Summary by CNBC
Telehealth firms Teladoc and LifeMD said they signed an agreement with Eli Lilly's pharmacy partner to offer patients the weight-loss drug, Zepbound.

Bias Distribution

  • 67% of the sources lean Right
67% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Gateway Pundit broke the news in United States on Thursday, March 6, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.